Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.
Masotti L, Landini G, Panigada G, Grifoni E, Tarquini R, Cei F, Cimolato BMA, Vannucchi V, Di Pietro M, Piani F, Fortini A, Faraone A, Nenci G, Cipollini F, Blanc P, Lotti P, Di Natale M, Risaliti F, Aquilini D, Seravalle C, Bribani A, Farsi A, Micheletti I, Cioni E, Pelagalli G, Mattaliano C, Pinto G, Madonia EM, Sivieri I, Mannini M, Valoriani A, Brancati S, Rosselli M, Pavone E, Burla MC, Sergi A; Department of Medical Specialties of Azienda USL Toscana Centro Covid-19 Group.
Masotti L, et al. Among authors: micheletti i.
Int Immunopharmacol. 2022 Jun;107:108709. doi: 10.1016/j.intimp.2022.108709. Epub 2022 Mar 18.
Int Immunopharmacol. 2022.
PMID: 35334359
Free PMC article.